CIK 0001497253
- Non-accelerated filer
- Smaller reporting company
VivoSim Labs, INC.
Sign in to watch- Ticker
- VIVS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271488943
- Phone
- +1 858-224-1000
- Business address
- 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
- Open-market buys, last 90 days
- $2,804
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-10-10 | David Eric Chief Strategy Officer | Sale | −3,530 | $5.66 | $20K | 747,776 |
| 2013-10-10 | David Eric Chief Strategy Officer | Option exercise · Warrant (Right to Buy) | −20,000 | 0 | ||
| 2013-10-07 | David Eric Chief Strategy Officer | Sale | −63,000 | $5.86 | $369K | 731,306 |
| 2013-10-02 | Presnell Sharon Collins EVP, Research & Dev & CTO | Sale | −75,000 | $5.64 | $423K | 74,064 |
| 2013-08-28 | Murphy Keith Chairman, CEO and President | Grant or award | +100,000 | 6,556,402 | ||
| 2013-08-28 | Murphy Keith Chairman, CEO and President | Shares withheld for taxes | −54,654 | $5.60 | $306K | 6,501,748 |
| 2013-08-28 | Murphy Keith Chairman, CEO and President | Grant or award · Stock Option (Right to Buy) | +54,654 | 54,654 | ||
| 2013-08-23 | MICHAELS BARRY D Chief Financial Officer | Shares withheld for taxes | −102,147 | $5.50 | $562K | 588,166 |
| 2013-08-23 | MICHAELS BARRY D Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +102,147 | 102,147 | ||
| 2013-08-21 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +30,500 | 30,500 | ||
| 2013-08-21 | Baltera Robert Jr. Director | Grant or award · Stock Option (Right to Buy) | +30,500 | 30,500 | ||
| 2013-08-21 | GLOVER JAMES T Director | Grant or award · Stock Option (Right to Buy) | +30,500 | 30,500 | ||
| 2013-08-21 | Heyman Richard A. Director | Grant or award · Stock Option (right to Buy) | +54,000 | 54,000 | ||
| 2013-08-21 | Heyman Richard A. Director | Grant or award · Stock Option (Right to Buy) | +30,500 | 30,500 | ||
| 2013-08-12 | Presnell Sharon Collins EVP, Research & Dev & CTO | Sale | −75,000 | $5.60 | $420K | 149,064 |
| 2013-06-05 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +45,500 | 45,500 | ||
| 2013-03-12 | Murphy Keith Chairman, CEO and President | Grant or award · Stock Option (Right to Buy) | +215,000 | 215,000 | ||
| 2013-03-12 | MICHAELS BARRY D Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2013-03-12 | Presnell Sharon Collins EVP, Research & Dev & CTO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2013-03-12 | David Eric Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 16 of 18 · 356 trades